Patient voice: The label given to my MS disease course matters to me—No

Lublin FD Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 1996; 46(4): 907–911.

Lublin FD Reingold SC Cohen JA , et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 2014; 83: 278–286.

Lublin FD Coetzee T Cohen JA , et al.; International Advisory Committee on Clinical Trials in MS. The 2013 clinical course descriptors for multiple sclerosis: A clarification. Neurology 2020; 94: 1088–1092.

Müller J Cagol A Lorscheider J , et al. Harmonizing definitions for progression independent of relapse activity in multiple sclerosis: A systematic review. JAMA Neurol 2023; 80(11): 1232–1245.

Van der Walt A Strijbis EMM Bridge F , et al. Advancing multiple sclerosis management in older adults. Nat Rev Neurol 2025; 21: 432–448.

Kuhlmann T Moccia M Coetzee T , et al. Multiple sclerosis progression: Time for a new mechanism-driven framework. Lancet Neurol 2023; 22(1): 78–88.

Thompson AJ Moccia M Amato MP , et al. Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community. Mult Scler 2023; 29(11–12): 1363–1372.

Bebo B . Updating how we classify ms and why it matters, https://www.nationalmssociety.org/news-and-magazine/momentum-magazine/from-the-community/updating-how-we-classify-ms

RealTalk MS. Episode 403: Moving toward a biologically based description of MS with Dr. Bruce Bebo, Dr. Daniel Ontaneda, and Kathy Smith, https://realtalkms.com/403